vs
Lantheus Holdings, Inc.（LNTH）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
Lantheus Holdings, Inc.的季度营收约是Revolve Group, Inc.的1.3倍（$406.8M vs $324.4M），Lantheus Holdings, Inc.净利率更高（13.3% vs 5.7%，领先7.6%），Revolve Group, Inc.同比增速更快（10.4% vs 4.0%），Lantheus Holdings, Inc.自由现金流更多（$81.4M vs $-13.3M），过去两年Revolve Group, Inc.的营收复合增速更高（9.5% vs 4.9%）
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
LNTH vs RVLV — 直观对比
营收规模更大
LNTH
是对方的1.3倍
$324.4M
营收增速更快
RVLV
高出6.4%
4.0%
净利率更高
LNTH
高出7.6%
5.7%
自由现金流更多
LNTH
多$94.7M
$-13.3M
两年增速更快
RVLV
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.8M | $324.4M |
| 净利润 | $54.1M | $18.6M |
| 毛利率 | 59.2% | 53.3% |
| 营业利润率 | 19.0% | 6.3% |
| 净利率 | 13.3% | 5.7% |
| 营收同比 | 4.0% | 10.4% |
| 净利润同比 | 558.8% | 50.4% |
| 每股收益（稀释后） | $0.86 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNTHRVLV
| Q4 25 | $406.8M | $324.4M | ||
| Q3 25 | $384.0M | $295.6M | ||
| Q2 25 | $378.0M | $309.0M | ||
| Q1 25 | $372.8M | $296.7M | ||
| Q4 24 | $391.1M | $293.7M | ||
| Q3 24 | $378.7M | $283.1M | ||
| Q2 24 | $394.1M | $282.5M | ||
| Q1 24 | $370.0M | $270.6M |
净利润LNTHRVLV
| Q4 25 | $54.1M | $18.6M | ||
| Q3 25 | $27.8M | $21.2M | ||
| Q2 25 | $78.8M | $10.2M | ||
| Q1 25 | $72.9M | $11.8M | ||
| Q4 24 | $-11.8M | $12.3M | ||
| Q3 24 | $131.1M | $11.0M | ||
| Q2 24 | $62.1M | $15.4M | ||
| Q1 24 | $131.1M | $10.9M |
毛利率LNTHRVLV
| Q4 25 | 59.2% | 53.3% | ||
| Q3 25 | 57.9% | 54.6% | ||
| Q2 25 | 63.8% | 54.1% | ||
| Q1 25 | 63.8% | 52.0% | ||
| Q4 24 | 63.5% | 52.5% | ||
| Q3 24 | 63.9% | 51.2% | ||
| Q2 24 | 64.9% | 54.0% | ||
| Q1 24 | 65.4% | 52.3% |
营业利润率LNTHRVLV
| Q4 25 | 19.0% | 6.3% | ||
| Q3 25 | 11.4% | 7.1% | ||
| Q2 25 | 23.3% | 5.8% | ||
| Q1 25 | 27.4% | 5.0% | ||
| Q4 24 | 29.1% | 3.9% | ||
| Q3 24 | 35.3% | 5.0% | ||
| Q2 24 | 26.1% | 5.8% | ||
| Q1 24 | 28.8% | 3.4% |
净利率LNTHRVLV
| Q4 25 | 13.3% | 5.7% | ||
| Q3 25 | 7.2% | 7.2% | ||
| Q2 25 | 20.8% | 3.3% | ||
| Q1 25 | 19.6% | 4.0% | ||
| Q4 24 | -3.0% | 4.2% | ||
| Q3 24 | 34.6% | 3.9% | ||
| Q2 24 | 15.8% | 5.4% | ||
| Q1 24 | 35.4% | 4.0% |
每股收益（稀释后）LNTHRVLV
| Q4 25 | $0.86 | $0.27 | ||
| Q3 25 | $0.41 | $0.29 | ||
| Q2 25 | $1.12 | $0.14 | ||
| Q1 25 | $1.02 | $0.16 | ||
| Q4 24 | $-0.18 | $0.18 | ||
| Q3 24 | $1.79 | $0.15 | ||
| Q2 24 | $0.88 | $0.21 | ||
| Q1 24 | $1.87 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $359.1M | $292.3M |
| 总债务越低越好 | $568.7M | — |
| 股东权益账面价值 | $1.1B | $512.5M |
| 总资产 | $2.2B | $765.0M |
| 负债/权益比越低杠杆越低 | 0.52× | — |
8季度趋势，按日历期对齐
现金及短期投资LNTHRVLV
| Q4 25 | $359.1M | $292.3M | ||
| Q3 25 | $382.0M | $315.4M | ||
| Q2 25 | $695.6M | $310.7M | ||
| Q1 25 | $938.5M | $300.8M | ||
| Q4 24 | $912.8M | $256.6M | ||
| Q3 24 | $866.4M | $252.8M | ||
| Q2 24 | $757.0M | $244.7M | ||
| Q1 24 | $718.3M | $273.4M |
总债务LNTHRVLV
| Q4 25 | $568.7M | — | ||
| Q3 25 | $567.9M | — | ||
| Q2 25 | $566.8M | — | ||
| Q1 25 | $566.1M | — | ||
| Q4 24 | $565.3M | — | ||
| Q3 24 | $613.0K | — | ||
| Q2 24 | $563.2M | — | ||
| Q1 24 | $562.5M | — |
股东权益LNTHRVLV
| Q4 25 | $1.1B | $512.5M | ||
| Q3 25 | $1.1B | $490.2M | ||
| Q2 25 | $1.2B | $468.6M | ||
| Q1 25 | $1.2B | $453.4M | ||
| Q4 24 | $1.1B | $437.8M | ||
| Q3 24 | $1.2B | $420.8M | ||
| Q2 24 | $1.0B | $405.8M | ||
| Q1 24 | $945.5M | $389.9M |
总资产LNTHRVLV
| Q4 25 | $2.2B | $765.0M | ||
| Q3 25 | $2.3B | $751.3M | ||
| Q2 25 | $2.1B | $722.9M | ||
| Q1 25 | $2.1B | $713.9M | ||
| Q4 24 | $2.0B | $665.5M | ||
| Q3 24 | $2.0B | $670.9M | ||
| Q2 24 | $1.9B | $657.8M | ||
| Q1 24 | $1.8B | $650.0M |
负债/权益比LNTHRVLV
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | 0.59× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $90.2M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $81.4M | $-13.3M |
| 自由现金流率自由现金流/营收 | 20.0% | -4.1% |
| 资本支出强度资本支出/营收 | 2.2% | 1.0% |
| 现金转化率经营现金流/净利润 | 1.67× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $354.1M | $48.0M |
8季度趋势，按日历期对齐
经营现金流LNTHRVLV
| Q4 25 | $90.2M | $-10.2M | ||
| Q3 25 | $105.3M | $11.8M | ||
| Q2 25 | $87.1M | $12.6M | ||
| Q1 25 | $107.6M | $45.1M | ||
| Q4 24 | $157.7M | $3.9M | ||
| Q3 24 | $175.1M | $9.1M | ||
| Q2 24 | $84.7M | $-24.7M | ||
| Q1 24 | $127.2M | $38.4M |
自由现金流LNTHRVLV
| Q4 25 | $81.4M | $-13.3M | ||
| Q3 25 | $94.7M | $7.5M | ||
| Q2 25 | $79.1M | $10.4M | ||
| Q1 25 | $98.8M | $43.4M | ||
| Q4 24 | $141.4M | $2.1M | ||
| Q3 24 | $159.3M | $8.0M | ||
| Q2 24 | $73.5M | $-25.7M | ||
| Q1 24 | $119.0M | $36.7M |
自由现金流率LNTHRVLV
| Q4 25 | 20.0% | -4.1% | ||
| Q3 25 | 24.7% | 2.5% | ||
| Q2 25 | 20.9% | 3.4% | ||
| Q1 25 | 26.5% | 14.6% | ||
| Q4 24 | 36.1% | 0.7% | ||
| Q3 24 | 42.0% | 2.8% | ||
| Q2 24 | 18.7% | -9.1% | ||
| Q1 24 | 32.2% | 13.5% |
资本支出强度LNTHRVLV
| Q4 25 | 2.2% | 1.0% | ||
| Q3 25 | 2.8% | 1.5% | ||
| Q2 25 | 2.1% | 0.7% | ||
| Q1 25 | 2.3% | 0.6% | ||
| Q4 24 | 4.2% | 0.6% | ||
| Q3 24 | 4.2% | 0.4% | ||
| Q2 24 | 2.8% | 0.4% | ||
| Q1 24 | 2.2% | 0.6% |
现金转化率LNTHRVLV
| Q4 25 | 1.67× | -0.55× | ||
| Q3 25 | 3.79× | 0.56× | ||
| Q2 25 | 1.11× | 1.24× | ||
| Q1 25 | 1.47× | 3.82× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | 1.34× | 0.83× | ||
| Q2 24 | 1.36× | -1.60× | ||
| Q1 24 | 0.97× | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
